A ray of sunshine to many COVID-19 patients who are in a battle with the deadly virus is the news that Postgraduate Institute of Medical Education and Research, Chandigarh's first coronavirus patient who was given convalescent plasma therapy has successfully recovered and been discharged on Friday.
A ray of sunshine to many COVID-19 patients who are in a battle with the deadly virus is the news that Postgraduate Institute of Medical Education and Research, Chandigarh's first coronavirus patient who was given convalescent plasma therapy has successfully recovered and been discharged on Friday.
The 60-year-old patient, hailing from Kurukshetra, Haryana was sent home with cheery applause by the medical team that treated him.
The Director of the institute Professor. Jagat Ram expressed his joy over the momentous occasion stating, "It is definitely encouraging news for all of us and I compliment the entire team for their untiring efforts to make it a success. This is the first patient at PGIMER who has received plasma therapy which is recommended for moderately ill Covid-19 patients. This noble cause needs to be propagated."
Convalescent plasma is obtained from patients who have recovered from COVID-19. Pegged as a useful tool in the initial stages of the novel coronavirus disease, the plasma therapy is seen as a beacon of hope. Those who have recovered from the disease are eligible to donate plasma, which would be then stored in a blood bank to treat the patients who are admitted with severe infection.
Detailing the nuances of the therapy, Professor GD Puri, the Dean and Head of the institute's Department of Anasthesia & Intensive Care, who played a pivotal role in the remarkable recovery, said, "The successful recovery with plasma therapy is a positive indicator. For plasma therapy clinical trials we need more donors to come forward. We have to counsel the recovered patients and their relatives to convince them to donate blood."
Professor Rati Ram, head of the Department of Transfusion Medicine, who was an integral part of the treatment team, said "This is a great moment for all of us at PGIMER Chandigarh, that one critically sick patient could be salvaged with the help of convalescent plasma therapy. We are highly grateful to our donors who came forward to donate plasma for this noble cause and hope that many more will follow so that we can provide the same to the needy patients in future as well."
The 60-year-old patient, hailing from Kurukshetra, Haryana was sent home with cheery applause by the medical team that treated him.
The Director of the institute Professor. Jagat Ram expressed his joy over the momentous occasion stating, "It is definitely encouraging news for all of us and I compliment the entire team for their untiring efforts to make it a success. This is the first patient at PGIMER who has received plasma therapy which is recommended for moderately ill Covid-19 patients. This noble cause needs to be propagated."
Convalescent plasma is obtained from patients who have recovered from COVID-19. Pegged as a useful tool in the initial stages of the novel coronavirus disease, the plasma therapy is seen as a beacon of hope. Those who have recovered from the disease are eligible to donate plasma, which would be then stored in a blood bank to treat the patients who are admitted with severe infection.
Detailing the nuances of the therapy, Professor GD Puri, the Dean and Head of the institute's Department of Anasthesia & Intensive Care, who played a pivotal role in the remarkable recovery, said, "The successful recovery with plasma therapy is a positive indicator. For plasma therapy clinical trials we need more donors to come forward. We have to counsel the recovered patients and their relatives to convince them to donate blood."
Professor Rati Ram, head of the Department of Transfusion Medicine, who was an integral part of the treatment team, said "This is a great moment for all of us at PGIMER Chandigarh, that one critically sick patient could be salvaged with the help of convalescent plasma therapy. We are highly grateful to our donors who came forward to donate plasma for this noble cause and hope that many more will follow so that we can provide the same to the needy patients in future as well."